Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.51 - $0.93 $8,133 - $14,831
-15,948 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.84 - $1.71 $86,764 - $176,627
-103,291 Reduced 86.63%
15,948 $13,000
Q4 2021

Feb 14, 2022

BUY
$1.59 - $2.38 $125,757 - $188,241
79,093 Added 197.01%
119,239 $195,000
Q3 2021

Nov 09, 2021

SELL
$1.69 - $2.89 $32,890 - $56,245
-19,462 Reduced 32.65%
40,146 $97,000
Q2 2021

Aug 13, 2021

BUY
$2.64 - $6.32 $154,725 - $370,402
58,608 Added 5860.8%
59,608 $157,000
Q1 2021

May 13, 2021

BUY
$1.35 - $4.99 $1,350 - $4,990
1,000 New
1,000 $5,000
Q3 2020

Nov 12, 2020

SELL
$0.6 - $1.25 $160 - $335
-268 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$0.42 - $1.51 $112 - $404
268 New
268 $0
Q1 2020

May 13, 2020

SELL
$0.47 - $1.56 $0 - $1
-1 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$0.72 - $1.52 $0 - $1
1 New
1 $0

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $40.5M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.